治愈癌症,是创新药皇冠上的明珠。现在,一家中国创新药企正参与这场医药界最高难度的“摘珠”行动中。这场行动的核心武器,是一种颠覆性的技术:mRNA,将彻底改变药物开发的底层逻辑。过去,制药是筛选分子的艺术,如今变成设计信息的科学。理论上,通过编写不同的mRNA序列,人体自身就能成为一座座精密的生物反应器,按指令生产出所需的任何蛋白质药物。这科幻般的疗法即将成药。Moderna与默沙东合作的个性化肿瘤...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.